Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Gert Jan Fleuren

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Anatomy

Procedures

Living Beings

Physiology

Immunologic Cytotoxicity

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Kenter Gemma G; Welters Marij J P; Valentijn A Rob P M; Lowik Margriet J G; Berends-van der Meer Dorien M A; Vloon Annelies P G; Essahsah Farah; Fathers Lorraine M; Offringa Rienk; Drijfhout Jan Wouter; Wafelman Amon R; Oostendorp Jaap; Fleuren Gert Jan; van der Burg Sjoerd H; Melief Cornelis J M
Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia.
de Vos van Steenwijk Peggy J; Piersma Sytse J; Welters Marij J P; van der Hulst Jeanette M; Fleuren Gertjan; Hellebrekers Bart W J; Kenter Gemma G; van der Burg Sjoerd H
Surgery followed by persistence of high-grade squamous intraepithelial lesions is associated with the induction of a dysfunctional HPV16-specific T-cell response.
Dierssen Jan Willem F; van Puijenbroek Marjo; Dezentjé David A; Fleuren Gert Jan; Cornelisse Cees J; van Wezel Tom; Offringa Rienk; Morreau Hans
Frequent mutations in the 3'-untranslated region of IFNGR1 lack functional impairment in microsatellite-unstable colorectal tumours.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Gert Jan Fleuren (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Kenter Gemma G; Welters Marij J P; Valentijn A Rob P M; Lowik Margriet J G; Berends-van der Meer Dorien M A; Vloon Annelies P G; Essahsah Farah; Fathers Lorraine M; Offringa Rienk; Drijfhout Jan Wouter; Wafelman Amon R; Oostendorp Jaap; Fleuren Gert Jan; van der Burg Sjoerd H; Melief Cornelis J M
Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia.
The New England journal of medicine 2009;361(19):1838-47.
2008: de Vos van Steenwijk Peggy J; Piersma Sytse J; Welters Marij J P; van der Hulst Jeanette M; Fleuren Gertjan; Hellebrekers Bart W J; Kenter Gemma G; van der Burg Sjoerd H
Surgery followed by persistence of high-grade squamous intraepithelial lesions is associated with the induction of a dysfunctional HPV16-specific T-cell response.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(22):7188-95.
2008: Dierssen Jan Willem F; van Puijenbroek Marjo; Dezentjé David A; Fleuren Gert Jan; Cornelisse Cees J; van Wezel Tom; Offringa Rienk; Morreau Hans
Frequent mutations in the 3'-untranslated region of IFNGR1 lack functional impairment in microsatellite-unstable colorectal tumours.
European journal of human genetics : EJHG 2008;16(10):1235-9.
2008: Vet J N I; de Boer M A; van den Akker B E W M; Siregar B; Lisnawati; Budiningsih S; Tyasmorowati D; Moestikaningsih; Cornain S; Peters A A W; Fleuren G J
Prevalence of human papillomavirus in Indonesia: a population-based study in three regions.
British journal of cancer 2008;99(1):214-8.
2008: Kloth Judith N; Kenter Gemma G; Spijker H Siebe; Uljee Sandra; Corver Willem E; Jordanova Ekaterina S; Fleuren Gert Jan; Gorter Arko
Expression of Smad2 and Smad4 in cervical cancer: absent nuclear Smad4 expression correlates with poor survival.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(7):866-75.
2008: van den Hende Muriel; van Poelgeest Mariëtte I E; van der Hulst Jeanette M; de Jong Joan; Drijfhout Jan W; Fleuren Gert Jan; Valentijn A Rob P M; Wafelman Amon R; Slappendel Gijs M; Melief Cornelis J M; Offringa Rienk; van der Burg Sjoerd H; Kenter Gemma G
Skin reactions to human papillomavirus (HPV) 16 specific antigens intradermally injected in healthy subjects and patients with cervical neoplasia.
International journal of cancer. Journal international du cancer 2008;123(1):146-52.
2008: Jordanova Ekaterina S; Gorter Arko; Ayachi Ouissam; Prins Frans; Durrant Lindy G; Kenter Gemma G; van der Burg Sjoerd H; Fleuren Gert Jan
Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients?
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(7):2028-35.
2008: Piersma Sytse J; Welters Marij J P; van der Hulst Jeanette M; Kloth Judith N; Kwappenberg Kitty M C; Trimbos Baptist J; Melief Cornelis J M; Hellebrekers Bart W; Fleuren Gert Jan; Kenter Gemma G; Offringa Rienk; van der Burg Sjoerd H
Human papilloma virus specific T cells infiltrating cervical cancer and draining lymph nodes show remarkably frequent use of HLA-DQ and -DP as a restriction element.
International journal of cancer. Journal international du cancer 2008;122(3):486-94.
2008: Welters Marij J P; Kenter Gemma G; Piersma Sytse J; Vloon Annelies P G; Löwik Margriet J G; Berends-van der Meer Dorien M A; Drijfhout Jan W; Valentijn A Rob P M; Wafelman Amon R; Oostendorp Jaap; Fleuren Gert Jan; Offringa Rienk; Melief Cornelis J M; van der Burg Sjoerd H
Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(1):178-87.
2008: Kenter Gemma G; Welters Marij J P; Valentijn A Rob P M; Lowik Margriet J G; Berends-van der Meer Dorien M A; Vloon Annelies P G; Drijfhout Jan W; Wafelman Amon R; Oostendorp Jaap; Fleuren Gert Jan; Offringa Rienk; van der Burg Sjoerd H; Melief Cornelis J M
Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(1):169-77.
2008: Kloth Judith N; Gorter Arko; ter Haar Natalja; Corver Willem E; Jordanova Ekaterina S; Kenter Gemma G; Fleuren Gert Jan
Lack of TNFalpha mRNA expression in cervical cancer is not associated with loss of heterozygosity at 6p21.3, inactivating mutations or promoter methylation.
Molecular immunology 2008;45(1):152-9.
2007: de Boer Marjon A; Jordanova Ekaterina S; van Poelgeest Mariëtte I E; van den Akker Brendy E; van der Burg Sjoerd H; Kenter Gemma G; Fleuren Gert Jan
Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts.
International journal of cancer. Journal international du cancer 2007;121(12):2711-5.
2007: Haven C J; van Puijenbroek M; Tan M H; Teh B T; Fleuren G J; van Wezel T; Morreau H
Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas.
Clinical endocrinology 2007;67(3):370-6.
2007: van der Burg Sjoerd H; Piersma Sytse J; de Jong Annemieke; van der Hulst Jeanette M; Kwappenberg Kitty M C; van den Hende Muriel; Welters Marij J P; Van Rood Jon J; Fleuren Gert Jan; Melief Cornelis J M; Kenter Gemma G; Offringa Rienk
Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigens.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(29):12087-92.
2007: Hazelbag S; Kenter G G; Gorter A; Dreef E J; Koopman L A; Violette S M; Weinreb P H; Fleuren G J
Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival.
The Journal of pathology 2007;212(3):316-24.
2007: Vermeulen Christine F W; Jordanova Ekaterina S; Szuhai Károly; Kolkman-Uljee Sandra; Vrede M Albert; Peters Alexander A W; Schuuring Ed; Fleuren Gert Jan
Physical status of multiple human papillomavirus genotypes in flow-sorted cervical cancer cells.
Cancer genetics and cytogenetics 2007;175(2):132-7.
2007: Vermeulen Christine F W; Jordanova Ekaterina S; ter Haar Natalja T; Kolkman-Uljee Sandra M; de Miranda Noel F; Ferrone Soldano; Peters Alexander A W; Fleuren Gert Jan
Expression and genetic analysis of transporter associated with antigen processing in cervical carcinoma.
Gynecologic oncology 2007;105(3):593-9.
2007: Mehta Akash M; Jordanova Ekaterina S; van Wezel Tom; Uh Hae-Won; Corver Willem E; Kwappenberg Kitty M C; Verduijn Willem; Kenter Gemma G; van der Burg Sjoerd H; Fleuren Gert J
Genetic variation of antigen processing machinery components and association with cervical carcinoma.
Genes, chromosomes & cancer 2007;46(6):577-86.
2007: Vermeulen C F W; Boon M E; Grünberg A; van der Linden-Narain I B S; Vrede M A; Dekker F W; Peters A A W; Fleuren G J
Decreased prevalence of dysplasia in high-risk population immigrants in a low-risk area for cervical cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2007;17(3):646-50.
2007: Tiersma E Stella M; Peters Alexander A W; van der Lee Marije L; Visser Adriaan P; Fleuren Gert Jan
Reasons for early interventions by gynaecologists in a clinical follow-up study on cervical intraepithelial neoplasia.
European journal of obstetrics, gynecology, and reproductive biology 2007;132(1):111-5.
2007: Pieterse Q D; Kenter G G; Gaarenstroom K N; Peters A A W; Willems S M; Fleuren G J; Trimbos J B M Z
The number of pelvic lymph nodes in the quality control and prognosis of radical hysterectomy for the treatment of cervical cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2007;33(2):216-21.
2007: Zijlmans Henry J M A A; Fleuren Gert Jan; Baelde Hans J; Eilers Paul H C; Kenter Gemma G; Gorter Arko
Role of tumor-derived proinflammatory cytokines GM-CSF, TNF-alpha, and IL-12 in the migration and differentiation of antigen-presenting cells in cervical carcinoma.
Cancer 2007;109(3):556-65.
2007: Piersma Sytse J; Jordanova Ekaterina S; van Poelgeest Mariëtte I E; Kwappenberg Kitty M C; van der Hulst Jeanette M; Drijfhout Jan W; Melief Cornelis J M; Kenter Gemma G; Fleuren Gert Jan; Offringa Rienk; van der Burg Sjoerd H
High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer.
Cancer research 2007;67(1):354-61.
2007: de Boer Marjon A; Jordanova Ekaterina S; Kenter Gemma G; Peters Alexander A; Corver Willem E; Trimbos J Baptist; Fleuren Gert Jan
High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(1):132-8.
2007: Dierssen Jan Willem F; de Miranda Noel F C C; Ferrone Soldano; van Puijenbroek Marjo; Cornelisse Cees J; Fleuren Gert Jan; van Wezel Tom; Morreau Hans
HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression.
BMC cancer 2007;7():33.
2007: Kloth Judith N; Oosting Jan; van Wezel Tom; Szuhai Karoly; Knijnenburg Jeroen; Gorter Arko; Kenter Gemma G; Fleuren Gert Jan; Jordanova Ekaterina S
Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
BMC genomics 2007;8():53.
2006: Sieben N L; Roemen G M J M; Oosting J; Fleuren G J; van Engeland M; Prat J
Clonal analysis favours a monoclonal origin for serous borderline tumours with peritoneal implants.
The Journal of pathology 2006;210(4):405-11.
2006: Vermeulen Christine F W; Grünberg Antoon; Peters Lex A W; van der Linden-Narain Ingrid B S; Vrede M Albert; Krul Eveline J T; Dekker Friedo W; Fleuren Gert Jan
Ethnic patterns of cytologic abnormalities in cervical smears in suriname, a high-risk area for cervical cancer.
Acta cytologica 2006;50(6):621-6.
2006: de Boer M A; Vet J N I; Aziz M F; Cornain S; Purwoto G; van den Akker B E W M; Dijkman A; Peters A A W; Fleuren G J
Human papillomavirus type 18 and other risk factors for cervical cancer in Jakarta, Indonesia.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16(5):1809-14.
2006: Sier Cornelis F M; Zuidwijk Kim; Zijlmans Henry J M A A; Hanemaaijer Roeland; Mulder-Stapel Adri A; Prins Frans A; Dreef Enno J; Kenter Gemma G; Fleuren Gert Jan; Gorter Arko
EMMPRIN-induced MMP-2 activation cascade in human cervical squamous cell carcinoma.
International journal of cancer. Journal international du cancer 2006;118(12):2991-8.
2006: Zijlmans H J M A A; Fleuren G J; Baelde H J; Eilers P H C; Kenter G G; Gorter A
The absence of CCL2 expression in cervical carcinoma is associated with increased survival and loss of heterozygosity at 17q11.2.
The Journal of pathology 2006;208(4):507-17.
2006: Welters Marij J P; van der Logt Pauline; van den Eeden Susan J F; Kwappenberg Kitty M C; Drijfhout Jan Wouter; Fleuren Gert Jan; Kenter Gemma G; Melief Cornelis J M; van der Burg Sjoerd H; Offringa Rienk
Detection of human papillomavirus type 18 E6 and E7-specific CD4+ T-helper 1 immunity in relation to health versus disease.
International journal of cancer. Journal international du cancer 2006;118(4):950-6.
2006: van Poelgeest Mariëtte I E; Nijhuis Esther R; Kwappenberg Kitty M C; Hamming Ineke E; Wouter Drijfhout Jan; Fleuren Gert Jan; van der Zee Ate G J; Melief Cornelis J M; Kenter Gemma G; Nijman Hans W; Offringa Rienk; van der Burg Sjoerd H
Distinct regulation and impact of type 1 T-cell immunity against HPV16 L1, E2 and E6 antigens during HPV16-induced cervical infection and neoplasia.
International journal of cancer. Journal international du cancer 2006;118(3):675-83.
2005: Vermeulen Christine F W; Jordanova Ekaterina S; Zomerdijk-Nooijen Yvon A; ter Haar Natalja T; Peters Alexander A W; Fleuren Gert Jan
Frequent HLA class I loss is an early event in cervical carcinogenesis.
Human immunology 2005;66(11):1167-73.
2005: Sieben Nathalie L G; Oosting Jan; Flanagan Adrienne M; Prat Jaime; Roemen Guido M J M; Kolkman-Uljee Sandra M; van Eijk Ronald; Cornelisse Cees J; Fleuren Gert Jan; van Engeland Manon
Differential gene expression in ovarian tumors reveals Dusp 4 and Serpina 5 as key regulators for benign behavior of serous borderline tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(29):7257-64.
2005: Kloth Judith N; Fleuren Gert Jan; Oosting Jan; de Menezes Renee X; Eilers Paul H C; Kenter Gemma G; Gorter Arko
Substantial changes in gene expression of Wnt, MAPK and TNFalpha pathways induced by TGF-beta1 in cervical cancer cell lines.
Carcinogenesis 2005;26(9):1493-502.
2005: Tiersma E S M; van der Lee M L; Garssen B; Peters A A W; Visser A P; Fleuren G J; van Leeuwen K M; le Cessie S; Goodkin K
Psychosocial factors and the course of cervical intra-epithelial neoplasia: a prospective study.
Gynecologic oncology 2005;97(3):879-86.
2005: Corver Willem E; Ter Haar Natalja T; Dreef Enno J; Miranda Noel F C C; Prins Frans A; Jordanova Ekaterina S; Cornelisse Cees J; Fleuren Gert Jan
High-resolution multi-parameter DNA flow cytometry enables detection of tumour and stromal cell subpopulations in paraffin-embedded tissues.
The Journal of pathology 2005;206(2):233-41.
2005: De Boer Marjon A; Peters Lex A W; Aziz Mohammed Farid; Siregar Budiningsih; Cornain Santoso; Vrede M Albert; Jordanova Ekaterina S; Fleuren Gert Jan
Human papillomavirus type 18 variants: histopathology and E6/E7 polymorphisms in three countries.
International journal of cancer. Journal international du cancer 2005;114(3):422-5.
2004: Hazelbag Suzanne; Kenter Gemma G; Gorter Arko; Fleuren Gert Jan
Prognostic relevance of TGF-beta1 and PAI-1 in cervical cancer.
International journal of cancer. Journal international du cancer 2004;112(6):1020-8.
2004: Haven Carola J; Howell Viive M; Eilers Paul H C; Dunne Robert; Takahashi Masayuki; van Puijenbroek Marjo; Furge Kyle; Kievit Job; Tan Min-Han; Fleuren Gert Jan; Robinson Bruce G; Delbridge Leigh W; Philips Jeanette; Nelson Anne E; Krause Ulf; Dralle Henning; Hoang-Vu Cuong; Gimm Oliver; Morreau Hans; Marsh Deborah J; Teh Bin T
Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype.
Cancer research 2004;64(20):7405-11.
2004: Trimbos J B; Lambeek A F; Peters A A W; Wolterbeek R; Gaarenstroom K N; Fleuren G J; Kenter G G
Prognostic difference of surgical treatment of exophytic versus barrel-shaped bulky cervical cancer.
Gynecologic oncology 2004;95(1):77-81.
2004: Ferber Matthew J; Eilers Paul; Schuuring Ed; Fenton James A L; Fleuren Gert Jan; Kenter Gemma; Szuhai Károly; Smith David I; Raap Anton K; Brink Antoinette A T P
Positioning of cervical carcinoma and Burkitt lymphoma translocation breakpoints with respect to the human papillomavirus integration cluster in FRA8C at 8q24.13.
Cancer genetics and cytogenetics 2004;154(1):1-9.
2004: de Boer Marjon A; Peters Lex A W; Aziz Mohammed Farid; Siregar Budiningsih; Cornain Santoso; Vrede M Albert; Jordanova Ekaterina S; Kolkman-Uljee Sandra; Fleuren Gert Jan
Human papillomavirus type 16 E6, E7, and L1 variants in cervical cancer in Indonesia, Suriname, and The Netherlands.
Gynecologic oncology 2004;94(2):488-94.
2004: de Jong Annemieke; van Poelgeest Mariëtte I E; van der Hulst Jeanette M; Drijfhout Jan Wouter; Fleuren Gert Jan; Melief Cornelis J M; Kenter Gemma; Offringa Rienk; van der Burg Sjoerd H
Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6.
Cancer research 2004;64(15):5449-55.
2004: Gelderman Kyra A; Kuppen Peter J K; Okada Noriko; Fleuren Gert Jan; Gorter Arko
Tumor-specific inhibition of membrane-bound complement regulatory protein Crry with bispecific monoclonal antibodies prevents tumor outgrowth in a rat colorectal cancer lung metastases model.
Cancer research 2004;64(12):4366-72.
2004: Schellekens Maaike C; Dijkman Anneke; Aziz Mohammad Farid; Siregar Budiningsih; Cornain Santoso; Kolkman-Uljee Sandra; Peters Lex A W; Fleuren Gert Jan
Prevalence of single and multiple HPV types in cervical carcinomas in Jakarta, Indonesia.
Gynecologic oncology 2004;93(1):49-53.
2004: Menon Anand G; Janssen-van Rhijn Connie M; Morreau Hans; Putter Hein; Tollenaar Rob A E M; van de Velde Cornelis J H; Fleuren Gert Jan; Kuppen Peter J K
Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis.
Laboratory investigation; a journal of technical methods and pathology 2004;84(4):493-501.
2004: Teh B T; Howell V M; Haven C J; Kahnoski K; Khoo S K; Petillo D; Chen J; Fleuren G J; Robinson B G; Delbridge L W; Philips J; Nelson A E; Krause U; Hammje K; Dralle H; Hoang-Vu C; Gimm O; Marsh D J; Morreau H
Human gene mutations. Gene symbol: HRPT2. Disease: Hyperparathyroidism Jaw-tumor syndrome.
Human genetics 2004;114(2):224.
2004: Teh B T; Howell V M; Haven C J; Kahnoski K; Khoo S K; Petillo D; Chen J; Fleuren G J; Robinson B G; Delbridge L W; Philips J; Nelson A E; Krause U; Hammje K; Dralle H; Hoang-Vu C; Gimm O; Marsh D J; Morreau H
Human gene mutations. Gene symbol: HRPT2. Disease: Hyperparathyroidism Jaw-tumor syndrome.
Human genetics 2004;114(2):223.
2004: Teh B T; Howell V M; Haven C J; Kahnoski K; Khoo S K; Petillo D; Chen J; Fleuren G J; Robinson B G; Delbridge L W; Philips J; Nelson A E; Krause U; Hammje K; Dralle H; Hoang-Vu C; Gimm O; Marsh D J; Morreau H
Human gene mutations. Gene symbol: HRPT2. Disease: Hyperparathyroidism Jaw-tumor syndrome.
Human genetics 2004;114(2):223.
2004: Teh B T; Howell V M; Haven C J; Kahnoski K; Khoo S K; Petillo D; Chen J; Fleuren G J; Robinson B G; Delbridge L W; Philips J; Nelson A E; Krause U; Hammje K; Dralle H; Hoang-Vu C; Gimm O; Marsh D J; Morreau H
Human gene mutations. Gene symbol: HRPT2. Disease: Hyperparathyroidism Jaw-tumor syndrome.
Human genetics 2004;114(2):223.
2004: Teh B T; Howell V M; Haven C J; Kahnoski K; Khoo S K; Petillo D; Chen J; Fleuren G J; Robinson B G; Delbridge L W; Philips J; Nelson A E; Krause U; Hammje K; Dralle H; Hoang-Vu C; Gimm O; Marsh D J; Morreau H
Human gene mutations. Gene symbol: HRPT2. Disease: Hyperparathyroidism Jaw-tumor syndrome.
Human genetics 2004;114(2):222.
2004: Teh B T; Howell V M; Haven C J; Kahnoski K; Khoo S K; Petillo D; Chen J; Fleuren G J; Robinson B G; Delbridge L W; Philips J; Nelson A E; Krause U; Hammje K; Dralle H; Hoang-Vu C; Gimm O; Marsh D J; Morreau H
Human gene mutations. Gene symbol: HRPT2. Disease: Hyperparathyroidism Jaw-tumor syndrome.
Human genetics 2004;114(2):222.
2004: Teh B T; Howell V M; Haven C J; Kahnoski K; Khoo S K; Petillo D; Chen J; Fleuren G J; Robinson B G; Delbridge L W; Philips J; Nelson A E; Krause U; Hammje K; Dralle H; Hoang-Vu C; Gimm O; Marsh D J; Morreau H
Human gene mutations. Gene symbol: HRPT2. Disease: Hyperparathyroidism Jaw-tumor syndrome.
Human genetics 2004;114(2):221.
2004: Haven Carola J; van Puijenbroek Marjo; Karperien Marcel; Fleuren Gert-Jan; Morreau Hans
Differential expression of the calcium sensing receptor and combined loss of chromosomes 1q and 11q in parathyroid carcinoma.
The Journal of pathology 2004;202(1):86-94.
2004: Menon Anand G; Tollenaar Rob A E M; van de Velde Cornelis J H; Putter Hein; Janssen-van Rhijn Connie M; Keijzer Rob; Fleuren Gert Jan; Kuppen Peter J K
p53 and HLA class-I expression are not down-regulated in colorectal cancer liver metastases.
Clinical & experimental metastasis 2004;21(1):79-85.
2003: Howell V M; Haven C J; Kahnoski K; Khoo S K; Petillo D; Chen J; Fleuren G J; Robinson B G; Delbridge L W; Philips J; Nelson A E; Krause U; Hammje K; Dralle H; Hoang-Vu C; Gimm O; Marsh D J; Morreau H; Teh B T
HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours.
Journal of medical genetics 2003;40(9):657-63.
2003: Tiersma E S M; Peters A A W; Mooij H A; Fleuren G J
Visualising scanning patterns of pathologists in the grading of cervical intraepithelial neoplasia.
Journal of clinical pathology 2003;56(9):677-80.
2003: Sieben Nathalie L G; Kolkman-Uljee Sandra M; Flanagan Adrienne M; le Cessie Saskia; Cleton-Jansen Anne-Marie; Cornelisse Cees J; Fleuren Gert Jan
Molecular genetic evidence for monoclonal origin of bilateral ovarian serous borderline tumors.
The American journal of pathology 2003;162(4):1095-101.
2003: Menon Anand G; Fleuren Gert Jan; Alphenaar Ellen A; Jonges Liesbeth E; Janssen van Rhijn Connie M; Ensink N Geeske; Putter Hein; Tollenaar Rob A E M; van de Velde Cornelis J H; Kuppen Peter J K
A basal membrane-like structure surrounding tumour nodules may prevent intraepithelial leucocyte infiltration in colorectal cancer.
Cancer immunology, immunotherapy : CII 2003;52(2):121-6.
2003: Welters Marij J P; de Jong Annemieke; van den Eeden Susan J F; van der Hulst Jeanette M; Kwappenberg Kitty M C; Hassane Sabrin; Franken Kees L M C; Drijfhout Jan Wouter; Fleuren Gert Jan; Kenter Gemma; Melief Cornelis J M; Offringa Rienk; van der Burg Sjoerd H
Frequent display of human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as witness of previous viral encounter.
Cancer research 2003;63(3):636-41.
2002: Hazelbag Suzanne; Gorter Arko; Kenter Gemma G; van den Broek Lambert; Fleuren Gertjan
Transforming growth factor-beta1 induces tumor stroma and reduces tumor infiltrate in cervical cancer.
Human pathology 2002;33(12):1193-9.
2002: Menon Anand G; Morreau Hans; Tollenaar Rob A E M; Alphenaar E; Van Puijenbroek Marjo; Putter Hein; Janssen-Van Rhijn Connie M; Van De Velde Cornelis J H; Fleuren Gert Jan; Kuppen Peter J K
Down-regulation of HLA-A expression correlates with a better prognosis in colorectal cancer patients.
Laboratory investigation; a journal of technical methods and pathology 2002;82(12):1725-33.
2002: Brink Antoinette A T P; Wiegant Joop C A G; Szuhai Károly; Tanke Hans J; Kenter Gemma G; Fleuren Gert-Jan; Schuuring Ed; Raap Anton K
Simultaneous mapping of human papillomavirus integration sites and molecular karyotyping in short-term cultures of cervical carcinomas by using 49-color combined binary ratio labeling fluorescence in situ hybridization.
Cancer genetics and cytogenetics 2002;134(2):145-50.
2002: Gelderman Kyra A; Blok Vanessa T; Fleuren Gert Jan; Gorter Arko
The inhibitory effect of CD46, CD55, and CD59 on complement activation after immunotherapeutic treatment of cervical carcinoma cells with monoclonal antibodies or bispecific monoclonal antibodies.
Laboratory investigation; a journal of technical methods and pathology 2002;82(4):483-93.
2002: Corver Willem E; Fleuren Gert Jan; Cornelisse Cees J
Software compensation improves the analysis of heterogeneous tumor samples stained for multiparameter DNA flow cytometry.
Journal of immunological methods 2002;260(1-2):97-107.
2002: Gelderman Kyra A; Kuppen Peter J K; Bruin Wouter; Fleuren Gert Jan; Gorter Arko
Enhancement of the complement activating capacity of 17-1A mAb to overcome the effect of membrane-bound complement regulatory proteins on colorectal carcinoma.
European journal of immunology 2002;32(1):128-35.
2001: Kuppen P J; Gorter A; Hagenaars M; Jonges L E; Giezeman-Smits K M; Nagelkerke J F; Fleuren G; van de Velde C J
Role of NK cells in adoptive immunotherapy of metastatic colorectal cancer in a syngeneic rat model.
Immunological reviews 2001;184():236-43.
2001: Szuhai K; Sandhaus E; Kolkman-Uljee S M; Lemaître M; Truffert J C; Dirks R W; Tanke H J; Fleuren G J; Schuuring E; Raap A K
A novel strategy for human papillomavirus detection and genotyping with SybrGreen and molecular beacon polymerase chain reaction.
The American journal of pathology 2001;159(5):1651-60.
2001: Hazelbag S; Fleuren G J; Baelde J J; Schuuring E; Kenter G G; Gorter A
Cytokine profile of cervical cancer cells.
Gynecologic oncology 2001;83(2):235-43.
2001: Jonges L E; Nagelkerke J F; Ensink N G; van der Velde E A; Tollenaar R A; Fleuren G J; van de Velde C J; Morreau H; Kuppen P J
Caspase-3 activity as a prognostic factor in colorectal carcinoma.
Laboratory investigation; a journal of technical methods and pathology 2001;81(5):681-8.
2001: Balzar M; Briaire-de Bruijn I H; Rees-Bakker H A; Prins F A; Helfrich W; de Leij L; Riethmüller G; Alberti S; Warnaar S O; Fleuren G J; Litvinov S V
Epidermal growth factor-like repeats mediate lateral and reciprocal interactions of Ep-CAM molecules in homophilic adhesions.
Molecular and cellular biology 2001;21(7):2570-80.
2001: van der Burg S H; Ressing M E; Kwappenberg K M; de Jong A; Straathof K; de Jong J; Geluk A; van Meijgaarden K E; Franken K L; Ottenhoff T H; Fleuren G J; Kenter G; Melief C J; Offringa R
Natural T-helper immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: identification of 3 human leukocyte antigen class II-restricted epitopes.
International journal of cancer. Journal international du cancer 2001;91(5):612-8.
2001: Koelemij R; Hagenaars M; Ensink N G; Eggermont A M; Van De Velde C J; Fleuren G J; Kuppen P J
Administration of BiMAb-retargeted T cells in a rat hepatic metastases colon tumour model results in T-cell tumour infiltration independent of the route of administration.
Scandinavian journal of immunology 2001;53(3):277-81.
2001: Jonges L E; Albertsson P; van Vlierberghe R L; Ensink N G; Johansson B R; van de Velde C J; Fleuren G J; Nannmark U; Kuppen P J
The phenotypic heterogeneity of human natural killer cells: presence of at least 48 different subsets in the peripheral blood.
Scandinavian journal of immunology 2001;53(2):103-10.
2001: Kuppen P J; van der Eb M M; Jonges L E; Hagenaars M; Hokland M E; Nannmark U; Goldfarb R H; Basse P H; Fleuren G J; Hoeben R C; van de Velde C J
Tumor structure and extracellular matrix as a possible barrier for therapeutic approaches using immune cells or adenoviruses in colorectal cancer.
Histochemistry and cell biology 2001;115(1):67-72.
2000: Hellebrekers B W; Zwinderman A H; Kenter G G; Peters A A; Fleuren G J; Trimbos J B
[Surgical treatment of early stage cervical carcinoma at Leids University Medical Center, 1984-1996: depth of invasion, number and bilaterality of metastatic lymph nodes prognostic for recurrence]
Nederlands tijdschrift voor geneeskunde 2000;144(48):2304-9.
2000: Jonges L E; Giezeman-Smits K M; van Vlierberghe R L; Ensink N G; Hagenaars M; Joly E; Eggermont A M; van de Velde C J; Fleuren G J; Kuppen P J
NK cells modulate MHC class I expression on tumor cells and their susceptibility to lysis.
Immunobiology 2000;202(4):326-38.
2000: Sieben N L; ter Haar N T; Cornelisse C J; Fleuren G J; Cleton-Jansen A M
PCR artifacts in LOH and MSI analysis of microdissected tumor cells.
Human pathology 2000;31(11):1414-9.
2000: Corver W E; Koopman L A; Mulder A; Cornelisse C J; Fleuren G J
Distinction between HLA class I-positive and -negative cervical tumor subpopulations by multiparameter DNA flow cytometry.
Cytometry 2000;41(1):73-80.
2000: Kersemaekers A M; van de Vijver M J; Fleuren G J
Comparison of the genetic alterations in two epithelial collision tumors of the uterine cervix. A report of two cases.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2000;19(3):225-30.
2000: Bonsing B A; Corver W E; Fleuren G J; Cleton-Jansen A M; Devilee P; Cornelisse C J
Allelotype analysis of flow-sorted breast cancer cells demonstrates genetically related diploid and aneuploid subpopulations in primary tumors and lymph node metastases.
Genes, chromosomes & cancer 2000;28(2):173-83.
2000: Gaarenstroom K N; Kenter G G; Bonfrer J M; Korse C M; Van de Vijver M J; Fleuren G J; Trimbos J B
Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
Gynecologic oncology 2000;77(1):164-70.
2000: Ressing M E; van Driel W J; Brandt R M; Kenter G G; de Jong J H; Bauknecht T; Fleuren G J; Hoogerhout P; Offringa R; Sette A; Celis E; Grey H; Trimbos B J; Kast W M; Melief C J
Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2000;23(2):255-66.
2000: Koopman L A; Corver W E; van der Slik A R; Giphart M J; Fleuren G J
Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer.
The Journal of experimental medicine 2000;191(6):961-76.
2000: Corver W E; Koopman L A; van der Aa J; Regensburg M; Fleuren G J; Cornelisse C J
Four-color multiparameter DNA flow cytometric method to study phenotypic intratumor heterogeneity in cervical cancer.
Cytometry 2000;39(2):96-107.
2000: Hagenaars M; Ensink N G; Eggermont A M; van der Velde E A; van de Velde C J; Fleuren G J; Kuppen P J
Endogenous natural killer cells do not play a role in antitumor effects induced by interleukin-2 in a syngeneic rat colon tumor model.
Cancer immunology, immunotherapy : CII 2000;48(10):561-8.
2000: Hagenaars M; Koelemij R; Ensink N G; van Eendenburg J D; van Vlierberghe R L; Eggermont A M; van de Velde C J; Fleuren G J; Kuppen P J
The development of novel mouse monoclonal antibodies against the CC531 rat colon adenocarcinoma.
Clinical & experimental metastasis 2000;18(4):281-9.
2000: Hagenaars M; Ensink N G; Basse P H; Hokland M; Nannmark U; Eggermont A M; van de Velde C J; Fleuren G J; Kuppen P J
The microscopic anatomy of experimental rat CC531 colon tumour metastases: consequences for immunotherapy?
Clinical & experimental metastasis 2000;18(2):189-96.
1999: Kersemaekers A M; van de Vijver M J; Kenter G G; Fleuren G J
Genetic alterations during the progression of squamous cell carcinomas of the uterine cervix.
Genes, chromosomes & cancer 1999;26(4):346-54.
1999: Koelemij R; Kuppen P J; van de Velde C J; Fleuren G J; Hagenaars M; Eggermont A M
Bispecific antibodies in cancer therapy, from the laboratory to the clinic.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1999;22(6):514-24.
1999: Koopman L A; Szuhai K; van Eendenburg J D; Bezrookove V; Kenter G G; Schuuring E; Tanke H; Fleuren G J
Recurrent integration of human papillomaviruses 16, 45, and 67 near translocation breakpoints in new cervical cancer cell lines.
Cancer research 1999;59(21):5615-24.
1999: Koopman L A; van Der Slik A R; Giphart M J; Fleuren G J
Human leukocyte antigen class I gene mutations in cervical cancer.
Journal of the National Cancer Institute 1999;91(19):1669-77.
1999: Krul E J; Kersemaekers A M; Zomerdijk-Nooyen Y A; Cornelisse C J; Peters L A; Fleuren G J
Different profiles of allelic losses in cervical carcinoma cases in Surinam and The Netherlands.
Cancer 1999;86(6):997-1004.
1999: de Boer C J; van Dorst E; van Krieken H; Jansen-van Rhijn C M; Warnaar S O; Fleuren G J; Litvinov S V
Changing roles of cadherins and catenins during progression of squamous intraepithelial lesions in the uterine cervix.
The American journal of pathology 1999;155(2):505-15.
1999: van Driel W J; Kievit-Tyson P; van den Broek L C; Zwinderman A H; Trimbos B J; Fleuren G J
Presence of an eosinophilic infiltrate in cervical squamous carcinoma results from a type 2 immune response.
Gynecologic oncology 1999;74(2):188-95.
1999: Giezeman-Smits K M; Gorter A; van Vlierberghe R L; v Eendenburg J D; Eggermont A M; Fleuren G J; Kuppen P J
The regulatory role of CD45 on rat NK cells in target cell lysis.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(1):71-6.
1999: van Driel W J; Ressing M E; Kenter G G; Brandt R M; Krul E J; van Rossum A B; Schuuring E; Offringa R; Bauknecht T; Tamm-Hermelink A; van Dam P A; Fleuren G J; Kast W M; Melief C J; Trimbos J B
Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I-II trial.
European journal of cancer (Oxford, England : 1990) 1999;35(6):946-52.
1999: Krul E J; Schipper R F; Schreuder G M; Fleuren G J; Kenter G G; Melief C J
HLA and susceptibility to cervical neoplasia.
Human immunology 1999;60(4):337-42.
1999: Kersemaekers A M; Fleuren G J; Kenter G G; Van den Broek L J; Uljee S M; Hermans J; Van de Vijver M J
Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(3):577-86.
1999: Hagenaars M; Ensink N G; Jonges L E; Chambers W H; Eggermont A M; van de Velde C J; Fleuren G J; Kuppen P J
The development of a bi-specific anti-CD161A x anti-tumor antibody for rat NK cell targeting.
Immunobiology 1999;200(1):31-48.
1999: van Driel W J; Kenter G G; Fleuren G J; Melief C J; Trimbos B J
Immunotherapeutic strategies for cervical squamous carcinoma.
Hematology/oncology clinics of North America 1999;13(1):259-73.
1999: Balzar M; Prins F A; Bakker H A; Fleuren G J; Warnaar S O; Litvinov S V
The structural analysis of adhesions mediated by Ep-CAM.
Experimental cell research 1999;246(1):108-21.
1998: Hagenaars M; Zwaveling S; Kuppen P J; Ensink N G; Eggermont A M; Hokland M E; Basse P H; van de Velde C J; Fleuren G J; Nannmark U
Characteristics of tumor infiltration by adoptively transferred and endogenous natural-killer cells in a syngeneic rat model: implications for the mechanism behind anti-tumor responses.
International journal of cancer. Journal international du cancer 1998;78(6):783-9.
1998: van Dorst E B; van Muijen G N; Litvinov S V; Fleuren G J
The limited difference between keratin patterns of squamous cell carcinomas and adenocarcinomas is explicable by both cell lineage and state of differentiation of tumour cells.
Journal of clinical pathology 1998;51(9):679-84.
1998: Velders M P; van Rhijn C M; Oskam E; Fleuren G J; Warnaar S O; Litvinov S V
The impact of antigen density and antibody affinity on antibody-dependent cellular cytotoxicity: relevance for immunotherapy of carcinomas.
British journal of cancer 1998;78(4):478-83.
1998: Kersemaekers A M; Kenter G G; Hermans J; Fleuren G J; van de Vijver M J
Allelic loss and prognosis in carcinoma of the uterine cervix.
International journal of cancer. Journal international du cancer 1998;79(4):411-7.
1998: Balzar M; Bakker H A; Briaire-de-Bruijn I H; Fleuren G J; Warnaar S O; Litvinov S V
Cytoplasmic tail regulates the intercellular adhesion function of the epithelial cell adhesion molecule.
Molecular and cellular biology 1998;18(8):4833-43.
1998: Koopman L A; Mulder A; Corver W E; Anholts J D; Giphart M J; Claas F H; Fleuren G J
HLA class I phenotype and genotype alterations in cervical carcinomas and derivative cell lines.
Tissue antigens 1998;51(6):623-36.
1998: Blok V T; Daha M R; Tijsma O; Harris C L; Morgan B P; Fleuren G J; Gorter A
A bispecific monoclonal antibody directed against both the membrane-bound complement regulator CD55 and the renal tumor-associated antigen G250 enhances C3 deposition and tumor cell lysis by complement.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(7):3437-43.
1998: Giezeman-Smits K M; Jonges L E; Chambers W H; Brisette-Storkus C S; Van Vlierberghe R L; Van Eendenburg J D; Eggermont A M; Fleuren G J; Kuppen P J
Novel monoclonal antibodies against membrane structures that are preferentially expressed on IL-2-activated rat NK cells.
Journal of leukocyte biology 1998;63(2):209-15.
1998: Hagenaars M; Ensink N G; Koelemij R; Basse P H; Eggermont A M; van de Velde C J; Fleuren G J; Kuppen P J
Regional administration of natural killer cells in a rat hepatic metastasis model results in better tumor infiltration and anti-tumor response than systemic administration.
International journal of cancer. Journal international du cancer 1998;75(2):233-8.
1998: Kersemaekers A M; Hermans J; Fleuren G J; van de Vijver M J
Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix.
British journal of cancer 1998;77(2):192-200.
1997: Abeln E C; Smit V T; Wessels J W; de Leeuw W J; Cornelisse C J; Fleuren G J
Molecular genetic evidence for the conversion hypothesis of the origin of malignant mixed müllerian tumours.
The Journal of pathology 1997;183(4):424-31.
1997: Litvinov S V; Balzar M; Winter M J; Bakker H A; Briaire-de Bruijn I H; Prins F; Fleuren G J; Warnaar S O
Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins.
The Journal of cell biology 1997;139(5):1337-48.
1997: Giezeman-Smits K M; Gorter A; Nagelkerke J F; van Vlierberghe R L; van Eendenburg J; Eggermont A M; Fleuren G J; Kuppen P J
Characterization of three new membrane structures on rat NK cells which are involved in activation of the lytic machinery.
Immunobiology 1997;197(5):429-43.
1997: Kagie M J; Kenter G G; Zomerdijk-Nooijen Y; Hermans J; Schuuring E; Timmers P J; Trimbos J B; Fleuren G J
Human papillomavirus infection in squamous cell carcinoma of the vulva, in various synchronous epithelial changes and in normal vulvar skin.
Gynecologic oncology 1997;67(2):178-83.
1997: Kagie M J; Kenter G G; Tollenaar R A; Hermans J; Trimbos J B; Fleuren G J
p53 protein overexpression is common and independent of human papillomavirus infection in squamous cell carcinoma of the vulva.
Cancer 1997;80(7):1228-33.
1997: Vierboom M P; Nijman H W; Offringa R; van der Voort E I; van Hall T; van den Broek L; Fleuren G J; Kenemans P; Kast W M; Melief C J
Tumor eradication by wild-type p53-specific cytotoxic T lymphocytes.
The Journal of experimental medicine 1997;186(5):695-704.
1997: Corver W E; Fleuren G J; Cornelisse C J
Improved single laser measurement of two cellular antigens and DNA-ploidy by the combined use of propidium iodide and TO-PRO-3 iodide.
Cytometry 1997;28(4):329-36.
1997: Bonsing B A; Corver W E; Gorsira M C; van Vliet M; Oud P S; Cornelisse C J; Fleuren G J
Specificity of seven monoclonal antibodies against p53 evaluated with Western blotting, immunohistochemistry, confocal laser scanning microscopy, and flow cytometry.
Cytometry 1997;28(1):11-24.
1997: Kagie M J; Kenter G G; Tollenaar R A; Hermans J; Trimbos J P; Fleuren G J
p53 protein overexpression, a frequent observation in squamous cell carcinoma of the vulva and in various synchronous vulvar epithelia, has no value as a prognostic parameter.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1997;16(2):124-30.
1997: Tollenaar R A; Bonsing B A; Kuipers-Dijkshoorn N J; Hermans J; van de Velde C J; Cornelisse C J; Fleuren G J
Evidence of clonal divergence in colorectal carcinoma.
Cancer 1997;79(7):1304-14.
1997: Hazelbag H M; Van den Broek L J; Fleuren G J; Taminiau A H; Hogendoorn P C
Distribution of extracellular matrix components in adamantinoma of long bones suggests fibrous-to-epithelial transformation.
Human pathology 1997;28(2):183-8.
1997: Kagie M J; Kenter G G; Hermans J; Trimbos J B; Fleuren G J
The relevance of various vulvar epithelial changes in the early detection of squamous cell carcinoma of the vulva.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 1997;7(1):50-7.
1997: Luiten R M; Warnaar S O; Schuurman J; Pasmans S G; Latour S; Daëron M; Fleuren G J; Litvinov S V
Chimeric immunoglobulin E reactive with tumor-associated antigen activates human Fc epsilon RI bearing cells.
Human antibodies 1997;8(4):169-80.
1996: van Bezooijen R L; Goey H; Stoter G; Hermans J; Fleuren G J
Prognostic markers for survival in patients with metastatic renal cell carcinoma treated with interleukin-2.
Cancer immunology, immunotherapy : CII 1996;43(5):293-8.
1996: van Driel W J; Ressing M E; Brandt R M; Toes R E; Fleuren G J; Trimbos J B; Kast W M; Melief C J
The current status of therapeutic HPV vaccine.
Annals of medicine 1996;28(6):471-7.
1996: Corver W E; Bonsing B A; Abeln E C; Vlak-Theil P M; Cornelisse C J; Fleuren G J
One-tube triple staining method for flow cytometric analysis of DNA ploidy and phenotypic heterogeneity of human solid tumors using single laser excitation.
Cytometry 1996;25(4):358-66.
1996: van Driel W J; Hogendoorn P C; Jansen F W; Zwinderman A H; Trimbos J B; Fleuren G J
Tumor-associated eosinophilic infiltrate of cervical cancer is indicative for a less effective immune response.
Human pathology 1996;27(9):904-11.
1996: Luiten R M; Coney L R; Fleuren G J; Warnaar S O; Litvinov S V
Generation of chimeric bispecific G250/anti-CD3 monoclonal antibody, a tool to combat renal cell carcinoma.
British journal of cancer 1996;74(5):735-44.
1996: Giezeman-Smits K M; Kuppen P J; Ensink N G; Eggermont A M; Stals F; Wonigeit K; Fleuren G J
The role of MHC class I expression in rat NK cell-mediated lysis of syngeneic tumor cells and virus-infected cells.
Immunobiology 1996;195(3):286-99.
1996: Velders M P; van Rhijn C M; Cornelissen I M; van Muijen G N; Briaire I H; Dohlsten M; Fleuren G J; Warnaar S O; Litvinov S V
The role of monoclonal antibody affinity in tumor immunotherapy evaluated in in vivo models for minimal residual disease.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1996;19(4):245-56.
1996: Schueler J A; Trimbos J B; vd Burg M; Cornelisse C J; Hermans J; Fleuren G J
DNA index reflects the biological behavior of ovarian carcinoma stage I-IIa.
Gynecologic oncology 1996;62(1):59-66.
1996: van Driel W J; Tjiong M Y; Hilders C G; Trimbos B J; Fleuren G J
Association of allele-specific HLA expression and histopathologic progression of cervical carcinoma.
Gynecologic oncology 1996;62(1):33-41.
1996: Gorter A; Blok V T; Haasnoot W H; Ensink N G; Daha M R; Fleuren G J
Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.
Laboratory investigation; a journal of technical methods and pathology 1996;74(6):1039-49.
1996: Kenter G G; Schoonderwald E M; Koelma I A; Arentz N; Hermans J; Fleuren G J
The cytological screening history of 469 patients with squamous cell carcinoma of the cervix uteri; does interval carcinoma exist?
Acta obstetricia et gynecologica Scandinavica 1996;75(4):400-3.
1996: Krul E J; Peters L A; Vandenbroucke J P; Vrede A; van Kanten R W; Fleuren G J
Cervical carcinoma in Surinam. Incidence and staging of cervical carcinoma between 1989 and 1994.
Cancer 1996;77(7):1329-33.
1996: Litvinov S V; van Driel W; van Rhijn C M; Bakker H A; van Krieken H; Fleuren G J; Warnaar S O
Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiation.
The American journal of pathology 1996;148(3):865-75.
1996: Luiten R M; Fleuren G J; Warnaar S O; Litvinov S V
Target-specific activation of mast cells by immunoglobulin E reactive with a renal cell carcinoma-associated antigen.
Laboratory investigation; a journal of technical methods and pathology 1996;74(2):467-75.
1996: Ressing M E; van Driel W J; Celis E; Sette A; Brandt M P; Hartman M; Anholts J D; Schreuder G M; ter Harmsel W B; Fleuren G J; Trimbos B J; Kast W M; Melief C J
Occasional memory cytotoxic T-cell responses of patients with human papillomavirus type 16-positive cervical lesions against a human leukocyte antigen-A *0201-restricted E7-encoded epitope.
Cancer research 1996;56(3):582-8.
1995: Hazelbag H M; Fleuren G J; Cornelisse C J; van den Broek L J; Taminiau A H; Hogendoorn P C
DNA aberrations in the epithelial cell component of adamantinoma of long bones.
The American journal of pathology 1995;147(6):1770-9.
1995: Abeln E C; Kuipers-Dijkshoorn N J; Berns E M; Henzen-Logmans S C; Fleuren G J; Cornelisse C J
Molecular genetic evidence for unifocal origin of advanced epithelial ovarian cancer and for minor clonal divergence.
British journal of cancer 1995;72(5):1330-6.
1995: Velders M P; van Rhijn C M; Briaire I H; Fleuren G J; Warnaar S O; Litvinov S V
Immunotherapy with low and high affinity monoclonal antibodies 17-1A and 323/A3 in a nude mouse xenograft carcinoma model.
Cancer research 1995;55(19):4398-403.
1995: van Ravenswaay Claasen H H; Fleuren G J
The influence of combination chemotherapy on antigen expression in ovarian cancer.
Gynecologic oncology 1995;58(1):16-23.
1995: Hilders C G; Munoz I M; Nooyen Y; Fleuren G J
Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.
Gynecologic oncology 1995;57(3):366-75.
1995: Fleuren G J; Gorter A; Kuppen P J; Litvinov S; Warnaar S O
Tumor heterogeneity and immunotherapy of cancer.
Immunological reviews 1995;145():91-122.
1995: Hazelbag H M; van den Broek L J; van Dorst E B; Offerhaus G J; Fleuren G J; Hogendoorn P C
Immunostaining of chain-specific keratins on formalin-fixed, paraffin-embedded tissues: a comparison of various antigen retrieval systems using microwave heating and proteolytic pre-treatments.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1995;43(4):429-37.
1995: Corver W E; Cornelisse C J; Hermans J; Fleuren G J
Limited loss of nine tumor-associated surface antigenic determinants after tryptic cell dissociation.
Cytometry 1995;19(3):267-72.
1994: Hazelbag H M; Taminiau A H; Fleuren G J; Hogendoorn P C
Adamantinoma of the long bones. A clinicopathological study of thirty-two patients with emphasis on histological subtype, precursor lesion, and biological behavior.
The Journal of bone and joint surgery. American volume 1994;76(10):1482-99.
1994: Devilee P; van Schothorst E M; Bardoel A F; Bonsing B; Kuipers-Dijkshoorn N; James M R; Fleuren G; van der Mey A G; Cornelisse C J
Allelotype of head and neck paragangliomas: allelic imbalance is confined to the long arm of chromosome 11, the site of the predisposing locus PGL.
Genes, chromosomes & cancer 1994;11(2):71-8.
1994: Abeln E C; Corver W E; Kuipers-Dijkshoorn N J; Fleuren G J; Cornelisse C J
Molecular genetic analysis of flow-sorted ovarian tumour cells: improved detection of loss of heterozygosity.
British journal of cancer 1994;70(2):255-62.
1994: van Velthuysen M L; Mayen A E; van Rooijen N; Fleuren G J; de Heer E; Bruijn J A
T cells and macrophages in Trypanosoma brucei-related glomerulopathy.
Infection and immunity 1994;62(8):3230-5.
1994: Hilders C G; Ras L; van Eendenburg J D; Nooyen Y; Fleuren G J
Isolation and characterization of tumor-infiltrating lymphocytes from cervical carcinoma.
International journal of cancer. Journal international du cancer 1994;57(6):805-13.
1994: Litvinov S V; Velders M P; Bakker H A; Fleuren G J; Warnaar S O
Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule.
The Journal of cell biology 1994;125(2):437-46.
1994: Velders M P; Litvinov S V; Warnaar S O; Gorter A; Fleuren G J; Zurawski V R; Coney L R
New chimeric anti-pancarcinoma monoclonal antibody with superior cytotoxicity-mediating potency.
Cancer research 1994;54(7):1753-9.
1994: van Duinen C M; van den Broek L J; Vermeer B J; Fleuren G J; Bruijn J A
The distribution of cellular adhesion molecules in pigmented skin lesions.
Cancer 1994;73(8):2131-9.
1994: Van den Broek L J; Hazelbag H M; Hilders C G; Fleuren G J
Antigen retrieval and microwaving.
European journal of morphology 1994;32(1):65-70.
1994: Corver W E; Cornelisse C J; Fleuren G J
Simultaneous measurement of two cellular antigens and DNA using fluorescein-isothiocyanate, R-phycoerythrin, and propidium iodide on a standard FACScan.
Cytometry 1994;15(2):117-28.
1994: Kuppen P J; Basse P H; Goldfarb R H; Van De Velde C J; Fleuren G J; Eggermont A M
The infiltration of experimentally induced lung metastases of colon carcinoma CC531 by adoptively transferred interleukin-2-activated natural killer cells in Wag rats.
International journal of cancer. Journal international du cancer 1994;56(4):574-9.
1994: van Dijk J; Uemura H; Beniers A J; Peelen W P; Zegveld S T; Fleuren G J; Warnaar S O; Oosterwijk E
Therapeutic effects of monoclonal antibody G250, interferons and tumor necrosis factor, in mice with renal-cell carcinoma xenografts.
International journal of cancer. Journal international du cancer 1994;56(2):262-8.
1994: Twaalfhoven F C; Fleuren G J; Cornelisse C J; Peters A A; Trimbos J B; Hogendoorn P C
Metastasis of breast carcinoma to a primary mucinous cystadenocarcinoma of the ovary.
Gynecologic oncology 1994;52(1):80-6.
1994: Kuppen P J; Eggermont A M; Quak R B; Marinelli A; van de Velde C J; Fleuren G J
Soluble factors produced by macrophages/monocytes inhibit lymphokine-activated killer activity in rat splenocyte cultures.
Cancer immunology, immunotherapy : CII 1994;38(1):61-7.
1994: Smits K M; Kuppen P J; Eggermont A M; Tamatani T; Miyasaka M; Fleuren G J
Rat interleukin-2-activated natural killer (A-NK) cell-mediated lysis is determined by the presence of CD18 on A-NK cells and the absence of major histocompatibility complex class I on target cells.
European journal of immunology 1994;24(1):171-5.
1994: Van Duinen C M; Fleuren G J; Bruijn J A
The extracellular matrix in pigmented skin lesions: an immunohistochemical study.
Histopathology 1994;24(1):33-40.
1994: Hilders C G; Houbiers J G; Krul E J; Fleuren G J
The expression of histocompatibility-related leukocyte antigens in the pathway to cervical carcinoma.
American journal of clinical pathology 1994;101(1):5-12.
1994: van Velthuysen M L; Mayen A E; Prins F A; de Heer E; Bruijn J A; Fleuren G J
Phagocytosis by glomerular endothelial cells in infection-related glomerulopathy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1994;9(8):1077-83.
1993: Hilders C G; Houbiers J G; van Ravenswaay Claasen H H; Veldhuizen R W; Fleuren G J
Association between HLA-expression and infiltration of immune cells in cervical carcinoma.
Laboratory investigation; a journal of technical methods and pathology 1993;69(6):651-9.
1993: Hazelbag H M; Fleuren G J; vd Broek L J; Taminiau A H; Hogendoorn P C
Adamantinoma of the long bones: keratin subclass immunoreactivity pattern with reference to its histogenesis.
The American journal of surgical pathology 1993;17(12):1225-33.
1993: Smits K M; Kuppen P J; Eggermont A M; Fleuren G J
Preincubation of tumor cells with the anti-(MHC) class I antibody OX18 enhances tumor cell lysis by interleukin-2-activated NK cells.
Transplantation proceedings 1993;25(5):2806-7.
1993: Smits K M; Kuppen P J; Lazeroms S P; Eggermont A M; Fleuren G J
Major histocompatibility complex class I expression and sensitivity to interleukin-2 activated NK cell-mediated lysis of adenovirus-transformed baby rat kidney cells.
Transplantation proceedings 1993;25(5):2804-5.
1993: van Ravenswaay Claasen H H; van de Griend R J; Mezzanzanica D; Bolhuis R L; Warnaar S O; Fleuren G J
Analysis of production, purification, and cytolytic potential of bi-specific antibodies reactive with ovarian-carcinoma-associated antigens and the T-cell antigen CD3.
International journal of cancer. Journal international du cancer 1993;55(1):128-36.
1993: Bonsing B A; Devilee P; Cleton-Jansen A M; Kuipers-Dijkshoorn N; Fleuren G J; Cornelisse C J
Evidence for limited molecular genetic heterogeneity as defined by allelotyping and clonal analysis in nine metastatic breast carcinomas.
Cancer research 1993;53(16):3804-11.
1993: Beun G D; van de Velde C J; Fleuren G J; Eggermont A M
T-cell retargeting using bispecific monoclonal antibodies in a rat colon carcinoma model: IV. Tumor neutralization in Winn type assays.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1993;14(1):11-5.
1993: Kuppen P J; Eggermont A M; Smits K M; van Eendenburg J D; Lazeroms S P; van de Velde C J; Fleuren G J
The development and purification of a bispecific antibody for lymphokine-activated killer cell targeting against the rat colon carcinoma CC531.
Cancer immunology, immunotherapy : CII 1993;36(6):403-8.
1993: Gorter A; van de Griend R J; van Eendenburg J D; Haasnoot W H; Fleuren G J
Production of bi-specific monoclonal antibodies in a hollow-fibre bioreactor.
Journal of immunological methods 1993;161(2):145-50.
1993: van Velthuysen M L; Veninga A; Bruijn J A; de Heer E; Fleuren G J
Susceptibility for infection-related glomerulopathy depends on non-MHC genes.
Kidney international 1993;43(3):623-9.
1993: Beun G D; Gorter A; Nooyen Y; van de Velde C J; Fleuren G J
T cell retargeting using bispecific monoclonal antibodies in a rat colon carcinoma model. II. Syngeneic colon carcinoma CC531 is efficiently killed by retargeted cytotoxic T lymphocytes in vitro despite limited lysis in 51Cr release assays.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(6):2305-15.
1993: Schueler J A; Cornelisse C J; Hermans J; Trimbos J B; van der Burg M E; Fleuren G J
Prognostic factors in well-differentiated early-stage epithelial ovarian cancer.
Cancer 1993;71(3):787-95.
1993: Bonsing B A; Beerman H; Kuipers-Dijkshoorn N; Fleuren G J; Cornelisse C J
High levels of DNA index heterogeneity in advanced breast carcinomas. Evidence for DNA ploidy differences between lymphatic and hematogenous metastases.
Cancer 1993;71(2):382-91.
1993: Kenter G G; Cornelisse C J; Jiwa N M; Aartsen E J; Hermans J; Mooi W; Heintz A P; Fleuren G J
Human papillomavirus type 16 in tumor tissue of low-stage squamous carcinoma of the uterine cervix in relation to ploidy grade and prognosis.
Cancer 1993;71(2):397-401.
1993: Hogendoorn P C; van Dorst E B; van der Burg S H; Bruijn J A; Daha M R; Hoedemaeker P J; Fleuren G J
Antigen size influences the type of glomerular pathology in chronic serum sickness.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1993;8(8):703-10.
1992: Kuppen P J; Marinelli A; Camps J A; Pauwels E K; van de Velde C J; Fleuren G J; Eggermont A M
Biodistribution of lymphokine-activated killer (LAK) cells in Wag rats after hepatic-artery or jugular-vein infusion.
International journal of cancer. Journal international du cancer 1992;52(2):266-70.
1992: van Ravenswaay Claasen H H; Kluin P M; Fleuren G J
Tumor infiltrating cells in human cancer. On the possible role of CD16+ macrophages in antitumor cytotoxicity.
Laboratory investigation; a journal of technical methods and pathology 1992;67(2):166-74.
1992: Beun G D; van Eendenburg D H; Corver W E; van de Velde C J; Fleuren G J
T-cell retargeting using bispecific monoclonal antibodies in a rat colon carcinoma model. I. Significant bispecific lysis of syngeneic colon carcinoma CC531 is critically dependent on prolonged preactivation of effector T-lymphocytes by immobilized anti-T-cell receptor antibody.
Journal of immunotherapy : official journal of the Society for Biological Therapy 1992;11(4):238-48.
1992: Gorter A; Krüse K M; Schrier P I; Fleuren G J; van de Griend R J
Enhancement of the lytic activity of cloned human CD8 tumour-infiltrating lymphocytes by bispecific monoclonal antibodies.
Clinical and experimental immunology 1992;87(1):111-6.
1992: Aten J; Stet R J; Wagenaar-Hilbers J P; Weening J J; Fleuren G J; Nieuwenhuis P
Glomerulopathy induced by graft-versus-host reaction in the rat. Requirement of donor CD4+ T lymphocytes and MHC class II incompatibility at the lymphoid compartment.
Scandinavian journal of immunology 1992;35(1):93-105.
1992: van Velthuysen M L; Bruijn J A; van Leer E H; Fleuren G J
Pathogenesis of trypanosomiasis-induced glomerulonephritis in mice.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1992;7(6):507-15.
1991: van Dijk J; Zegveld S T; Fleuren G J; Warnaar S O
Localization of monoclonal antibody G250 and bispecific monoclonal antibody CD3/G250 in human renal-cell carcinoma xenografts: relative effects of size and affinity.
International journal of cancer. Journal international du cancer 1991;48(5):738-43.
1991: Twaalfhoven F C; Peters A A; Trimbos J B; Hermans J; Fleuren G J
The accuracy of frozen section diagnosis of ovarian tumors.
Gynecologic oncology 1991;41(3):189-92.
1991: van der Mey A G; Cornelisse C J; Hermans J; Terpstra J L; Schmidt P H; Fleuren G J
DNA flow cytometry of hereditary and sporadic paragangliomas (glomus tumours).
British journal of cancer 1991;63(2):298-302.
1991: Trimbos J B; Schueler J A; van der Burg M; Hermans J; van Lent M; Heintz A P; Fleuren G J
Watch and wait after careful surgical treatment and staging in well-differentiated early ovarian cancer.
Cancer 1991;67(3):597-602.
1991: Offerhaus G J; Giardiello F M; Bruijn J A; Stijnen T; Molyvas E N; Fleuren G J
The value of immunohistochemistry for collagen IV expression in colorectal carcinomas.
Cancer 1991;67(1):99-105.
1991: Hoedemaeker P J; Aten J; Hogendoorn P C; Kawasaki K; van Leer E H; de Heer E; Fleuren G J
Pathogenesis of glomerulonephritis: experimental models revisited.
Advances in nephrology from the Necker Hospital 1991;20():73-90.
1991: Kuppen P J; Eggermont A M; Marinelli A; de Heer E; van de Velde C J; Fleuren G J
Induction of lymphokine-activated killer activity in rat splenocyte cultures: the importance of 2-mercaptoethanol and indomethacin.
Cancer immunology, immunotherapy : CII 1991;33(1):28-32.
1990: Trimbos J B; Peters A A; Kenter G G; Nooy M A; Fleuren G J
[Lessons from gynecological-pathological discussions]
Nederlands tijdschrift voor geneeskunde 1990;134(49):2399-401.
1990: Kenter G G; Cornelisse C J; Aartsen E J; Mooy W; Hermans J; Heintz A P; Fleuren G J
DNA ploidy level as prognostic factor in low stage carcinoma of the uterine cervix.
Gynecologic oncology 1990;39(2):181-5.
1990: Smit V T; Fleuren G J; van Houwelingen J C; Zegveld S T; Kuipers-Dijkshoorn N J; Cornelisse C J
Flow cytometric DNA-ploidy analysis of synchronously occurring multiple malignant tumors of the female genital tract.
Cancer 1990;66(8):1843-9.
1990: Bruijn J A; van Leer E H; Baelde H J; Corver W E; Hogendoorn P C; Fleuren G J
Characterization and in vivo transfer of nephritogenic autoantibodies directed against dipeptidyl peptidase IV and laminin in experimental lupus nephritis.
Laboratory investigation; a journal of technical methods and pathology 1990;63(3):350-9.
1990: Trimbos J B; Schueler J A; van Lent M; Hermans J; Fleuren G J
Reasons for incomplete surgical staging in early ovarian carcinoma.
Gynecologic oncology 1990;37(3):374-7.
1990: Bruijn J A; Hogendoorn P C; Corver W E; van den Broek L J; Hoedemaeker P J; Fleuren G J
Pathogenesis of experimental lupus nephritis: a role for anti-basement membrane and anti-tubular brush border antibodies in murine chronic graft-versus-host disease.
Clinical and experimental immunology 1990;79(1):115-22.
1990: Hogendoorn P C; Bruijn J A; Gelok E W; Van den Broek L J; Fleuren G J
Development of progressive glomerulosclerosis in experimental chronic serum sickness.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1990;5(2):100-9.
1989: Bruijn J A; Hoedemaeker P J; Fleuren G J
Pathogenesis of anti-basement membrane glomerulopathy and immune-complex glomerulonephritis: dichotomy dissolved.
Laboratory investigation; a journal of technical methods and pathology 1989;61(5):480-8.
1989: Van Dijk J; Tsuruo T; Segal D M; Bolhuis R L; Colognola R; van de Griend R J; Fleuren G J; Warnaar S O
Bispecific antibodies reactive with the multidrug-resistance-related glycoprotein and CD3 induce lysis of multidrug-resistant tumor cells.
International journal of cancer. Journal international du cancer 1989;44(4):738-43.
1989: Bruijn J A; Van Elven E H; Corver W E; Oudshoorn-Snoek M; Fleuren G J
Genetics of experimental lupus nephritis: non-H-2 factors determine susceptibility for renal involvement in murine chronic graft-versus-host disease.
Clinical and experimental immunology 1989;76(2):284-9.
1989: van Dijk J; Warnaar S O; van Eendenburg J D; Thienpont M; Braakman E; Boot J H; Fleuren G J; Bolhuis R L
Induction of tumor-cell lysis by bi-specific monoclonal antibodies recognizing renal-cell carcinoma and CD3 antigen.
International journal of cancer. Journal international du cancer 1989;43(2):344-9.
1988: Koelma I A; Nap M; van Steenis G J; Fleuren G J
Tumor markers for ovarian cancer. A comparative immunohistochemical and immunocytochemical study of two commercial monoclonal antibodies (OV632 and OC125).
American journal of clinical pathology 1988;90(4):391-6.
1988: Smit V T; Cornelisse C J; De Jong D; Dijkshoorn N J; Peters A A; Fleuren G J
Analysis of tumor heterogeneity in a patient with synchronously occurring female genital tract malignancies by DNA flow cytometry, DNA fingerprinting, and immunohistochemistry.
Cancer 1988;62(6):1146-52.
1988: Angeli S; Koelma I A; Fleuren G J; Van Steenis G J
Malignant melanoma in fine needle aspirates and effusions. An immunocytochemical study using monoclonal antibodies.
Acta cytologica 1988;32(5):707-12.
1988: Smit V T; Boot A J; Smits A M; Fleuren G J; Cornelisse C J; Bos J L
KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas.
Nucleic acids research 1988;16(16):7773-82.
1988: Fleuren G J; Nap M
Carcinoembryonic antigen in primary and metastatic ovarian tumors.
Gynecologic oncology 1988;30(3):407-15.
1988: van Dijk J; Oosterwijk E; van Kroonenburgh M J; Jonas U; Fleuren G J; Pauwels E K; Warnaar S O
Perfusion of tumor-bearing kidneys as a model for scintigraphic screening of monoclonal antibodies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1988;29(6):1078-82.
1988: Bruijn J A; van Elven E H; Hogendoorn P C; Corver W E; Hoedemaeker P J; Fleuren G J
Murine chronic graft-versus-host disease as a model for lupus nephritis.
The American journal of pathology 1988;130(3):639-41.
1988: Hogendoorn P C; Bruijn J A; vd Broek L J; De Heer E; Foidart J M; Hoedemaeker P J; Fleuren G J
Antibodies to purified renal tubular epithelial antigens contain activity against laminin, fibronectin, and type IV collagen.
Laboratory investigation; a journal of technical methods and pathology 1988;58(3):278-86.
1988: Rodenburg C J; Cornelisse C J; Hermans J; Fleuren G J
DNA flow cytometry and morphometry as prognostic indicators in advanced ovarian cancer: a step forward in predicting the clinical outcome.
Gynecologic oncology 1988;29(2):176-87.
1988: Rodenburg C J; Koelma I A; Nap M; Fleuren G J
Immunohistochemical detection of the ras oncogene product p21 in advanced ovarian cancer. Lack of correlation with clinical outcome.
Archives of pathology & laboratory medicine 1988;112(2):151-4.
1988: Maes G; Fleuren G J; Bara J; Nap M
The distribution of mucins, carcinoembryonic antigen, and mucus-associated antigens in endocervical and endometrial adenocarcinomas.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1988;7(2):112-22.
1987: Fleuren G J; Nap M; Aalders J G; Trimbos J B; de Bruijn H W
Explanation of the limited correlation between tumor CA 125 content and serum CA 125 antigen levels in patients with ovarian tumors.
Cancer 1987;60(10):2437-42.
1987: Bruijn J A; Oemar B S; Ehrich J H; Foidart J M; Fleuren G J
Anti-basement membrane glomerulopathy in experimental trypanosomiasis.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(7):2482-8.
1987: Koelma I A; Nap M; Rodenburg C J; Fleuren G J
The value of tumour marker CA 125 in surgical pathology.
Histopathology 1987;11(3):287-94.
1987: Bruijn J A; Smit V T; Que D G; Fleuren G J
Immunohistology of a sarcomatous mural nodule in an ovarian mucinous cystadenocarcinoma.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1987;6(3):287-93.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Gert Jan Fleuren

Research Profile (preview)

Disorders

Chemicals & Drugs

Anatomy

Procedures

Living Beings

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Gert Jan Fleuren (preview)

All Publications